Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mid-follicular Luveris in controlled ovarian stimulation for women of advanced reproductive age
2006-005268-19Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of lutropin alfa in female infertility (2 arms), sponsored by Merck & Co. Primary endpoints: Total number of oocytes retrieved, Number of metaphase II oocytes and 1 more. Started Mar 2012; status: completed.
02
Drugs
lutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on 2006-005268-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005268-19.